Fund Management at Engine No 1’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Fund Management at Engine No 1’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-2,951	Closed	-$304K	–	455
2023 Q2	$304K	Buy	2,951 +202	+7%	+$21.3K	0.06%	330
2023 Q1	$300K	Buy	2,749 +255	+10%	+$28.2K	0.06%	313
2022 Q4	$284K	Buy	+2,494	New	+$207K	0.07%	283
2022 Q2	–	Sell	-1,920	Closed	-$202K	–	369
2022 Q1	$202K	Buy	+1,920	New	+$187K	0.05%	346

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fund Management at Engine No 1's HZNP Position: Q3 2023 in Review

Fund Management at Engine No 1 sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q3 2023, closing a stake of 2,951 shares — an estimated $304K sold.

Fund Management at Engine No 1 first reported a position in HZNP in Q1 2022 and held it in 4 quarters. The position peaked at $304K in Q2 2023. 485 funds tracked by Wall St. Rank hold HZNP as of Q3 2023.

Fund Management at Engine No 1 reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q3 2023 after selling out during the quarter.
Fund Management at Engine No 1 sold 2,951 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q3 2023, an estimated $304K.
Fund Management at Engine No 1 first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2022 and held it in 4 quarters.
Fund Management at Engine No 1's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $304K in Q2 2023.
485 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q3 2023.

Based on Fund Management at Engine No 1's 13F filing for Q3 2023, filed 14 Nov 2023.